Lubner David Charles 4
4 · Dyne Therapeutics, Inc. · Filed May 24, 2024
Insider Transaction Report
Form 4
Lubner David Charles
Director
Transactions
- Award
Stock option (right to buy)
2024-05-22+25,133→ 25,133 totalExercise: $31.53Exp: 2034-05-21→ Common Stock (25,133 underlying)
Footnotes (1)
- [F1]This option was granted on May 22, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 22, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to continued service.